Buy ImmunoCellular Therapeutics Stock | IMUC Stock Price & Latest News | Public
IMUC

ImmunoCellular Therapeutics

    Small Market Cap

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    About IMUC

    ImmunoCellular Therapeutics, Ltd. is a clinical-stage company, which engages in the development of immune-based therapies for the treatment of cancers. The company's lead product candidate, ICT-107, is a dendritic cell-based immunotherapy targeting multiple tumor-associ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    Stats

    Market Cap$1M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$0.51
    1 Year Low$0.16
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app